Introduction {#S1}
============

It has been estimated that in chronic haemodialysis patients, vascular access morbidity is responsible for 25% of all hospital admissions \[[@R1]\]. The main cause of dysfunction of arteriovenous grafts (AVG) and arteriovenous fistula (AVF) is stenosis (and subsequent thrombosis), which is primarily related to the vascular remodelling and adaptation to high-flow conditions. The rationale for implementing a vascular access surveillance programme is that timely detection of stenosis combined with either radiological and/or surgical pre-emptive intervention could reduce thrombotic occlusive events and may prolong access life.

The recently updated K/DOQI clinical practice guidelines for vascular access \[[@R2]\] and the European Best Practice Guidelines on Vascular Access \[[@R3]\] advocate such surveillance programmes. These guidelines state that monitoring for stenosis during dialysis treatment (online monitoring) is preferred compared to Duplex ultrasound or magnetic resonance angiography (MRA) monitoring for practical and economical reasons. Several online monitoring tools are available, of which access flow (Qa) monitoring is generally considered as the best surveillance method \[[@R2]\]. Online Qa evaluation is defined as measurement of access flow using a technique that is inherently linked to the presence of the extracorporeal circulation during haemodialysis treatment. A Qa \<600 ml/min (AVG), a Qa \<400 ml/min (AVF) or a Qa decline of \>25% versus previous measurement (AVG) is an indication for pre-emptive intervention \[[@R2]\]. Whether Qa surveillance can prolong access survival is currently unproven. However, the guidelines state that thrombosis frequency is an important outcome parameter as well. Almost 60% of patients cite access thrombosis as one of the most feared complications associated with haemodialysis vascular access, ranking it second only to pain \[[@R5]\]. Moreover, a dysfunctional access (even before thrombosis occurs) may result in less optimal dialysis \[[@R6]\].

However, despite guideline recommendations, there is still discussion \[[@R7]\] on the benefits of online Qa surveillance in dialysis patients.

With the help of a systematic literature search, we provide an overview of all studies that compared online Qa surveillance combined with pre-emptive intervention to suggested \[[@R2]\] alternative or conservative surveillance tools and the effect on thrombosis frequency.

Methods {#S2}
=======

An electronic database search was carried out using Medline (Pubmed). As online vascular access flow measurement techniques were not introduced before 1995, the search was limited to the time frame between January 1995, till September 2007. Search terms were 'Vascular access flow OR Vascular access monitoring OR Vascular access surveillance OR Preemptive intervention AND Vascular access thrombosis OR Vascular access occlusion'. Only publications in English were included. The outcome measure was the number of occlusions per patient per year. Reference lists from all relevant review articles were searched by hand. All such studies were included that compared none or different surveillance techniques for surveillance with online Qa surveillance. Included participants were male and female adult patients (age \>18 years) on chronic haemodialysis for end-stage renal disease with both AVG and AVF.

Results {#S3}
=======

Description of studies {#S3-1}
----------------------

### Trials identified. {#S3-1-1}

In total, 524 articles were retrieved. Four hundred ninety articles were eliminated using title and abstract. The remaining 34 articles were fully assessed and 8 were finally included for the review.

Excluded studies {#S3-2}
----------------

A total of 26 studies were excluded after reading the entire manuscript (Table [1](#T1){ref-type="table"}). The reasons for excluding trials were

###### 

Excluded articles after full assessment

  Study ID                Reason for exclusion
  ----------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Besarab \[[@R7]\]       Review
  Paulson \[[@R8]\]       Review
  Sands \[[@R9]\]         Review
  Work \[[@R10]\]         Review
  Arbabzadah \[[@R11]\]   Evaluation of AVG that clot despite online Qa surveillance and the outcome of radiological thrombectomy
  Bosman \[[@R12]\]       Study whether high dynamic venous pressure coincides with low AVG flow, measured by the ultrasound dilution technique
  Cayco \[[@R13]\]        Comparison of a surveillance programme based on dynamic venous pressure with a historical group during which no surveillance was applied, in relation to AVG thrombosis incidence
  Cinat \[[@R14]\]        Evaluation of the patency, complications and predictive factors of patency for AVG
  Dember \[[@R15]\]       Comparison between prophylactic repair of AVG stenosis based on static venous pressure and repair at the time of thrombosis, in relation to graft survival
  Dossabhoy \[[@R16]\]    Replication of data from other study \[[@R36]\]
  Frinak \[[@R17]\]       Sensitivity and specificity of a dynamic venous access ratio test for access surveillance
  Garland \[[@R18]\]      Review (Qa measurement by ultrasound dilution the standard of care for access surveillance?)
  Goldstein \[[@R19]\]    Age of participants \<18 years
  Lumsden \[[@R20]\]      Prospective randomized trial to compare patients who underwent PTA for AVG (stenosis \>50%) with a control group that received no intervention, towards AVG survival. Surveillance tool: duplex ultrasound
  Magnesco \[[@R21]\]     Comparison of two online Qa measurement techniques
  Maya \[[@R22]\]         Comparison of outcomes of elective angioplasty between AVF and AVG
  Neyra \[[@R23]\]        Evaluation of the predictive value of the Qa decrease towards thrombosis risk
  Plantinga \[[@R24]\]    Effect of clinic vascular access monitoring practices towards clinical outcomes in haemodialysis patients
  Roberts \[[@R25]\]      Study towards the value of a surveillance programme based on measuring venous resistance, regarding AVG patency and survival
  Safa \[[@R26]\]         To determine the value of a haemodialysis graft surveillance programme in reducing the incidence of AVG thrombosis and prolonging graft patency by means of pre-emptive intervention (PTA) of graft-related stenoses (no online Qa surveillance applied)
  Sands \[[@R27]\]        Review
  Sands \[[@R28]\]        Effect of pre-emptive intervention towards access survival. No online Qa surveillance used
  Singh \[[@R29]\]        Comparison predictive accuracy static venous pressure, dynamic venous pressure and access flow in determining subsequent graft thrombosis
  Tanuma \[[@R30]\]       Evaluation of the long-term results of vascular access, in particular the effects of PTA
  Tessitore \[[@R31]\]    Predictive value of online Qa surveillance in AVF towards thrombosis, and sensitivity towards stenosis detection
  Tonelli \[[@R32]\]      Review

AVF = arteriovenous fistula; AVG = arteriovenous graft; Qa = vascular access flow.

1.  review articles (7) \[[@R7],[@R18],[@R27],[@R32]\];

2.  age of participants \<18 years (1) \[[@R19]\];

3.  analyses focused only on sensitivity of Qa surveillance (4) \[[@R23],[@R29],[@R31]\];

4.  no online Qa surveillance used (8) \[[@R13],[@R15],[@R17],[@R20],[@R22], [@R25],[@R26],[@R28]\];

5.  replication of data from other studies (1) \[[@R16]\];

6.  study regarding the effect of percutaneous transluminal angioplasty (PTA) (1) \[[@R30]\];

7.  evaluation of AVG which thrombosed despite Qa surveillance (1) \[[@R11]\];

8.  study evaluating the relation of high dynamic venous pressure and low Qa in AVG (1) \[[@R12]\];

9.  prospective evaluation of AVG patency (1) \[[@R14]\] and

10. comparison of two online Qa measurement techniques (1) \[[@R21]\].

Included studies {#S3-3}
----------------

The remaining eight trials and their results are presented in Table [2](#T2){ref-type="table"}. A significant overall (AVF and AVG) decline in thrombosis was reported four times \[[@R33],[@R37],[@R38],[@R40]\]. Five trials reported a thrombosis reduction in AVF \[[@R34],[@R38]\], of which two were significant \[[@R38],[@R40]\]. A thrombosis decline in AVG was reported four times \[[@R34],[@R38],[@R40]\], of which one was not significant \[[@R38]\]. An increase in AVG thrombosis was reported once \[[@R36]\]. The first choice for pre-emptive intervention was PTA in all eight trials. PTA was executed in the case of stenosis with ≥50% area reduction. Three studies \[[@R33]\] reported surgery used for pre-emptive intervention when PTA was not feasible. All studies reported an increase in radiological procedures. Despite the significant increase in radiological procedures, two studies \[[@R35],[@R40]\] reported a cost reduction during the online Qa surveillance period compared to the control group(s).

###### 

Study design and online Qa surveillance results expressed in thrombosis/patient-year

                                                                             Patient numbers   Thrombosis/patient-year                                                                                                                  
  --------------------- ------ --------------------------------------------- ----------------- ------------------------- --------------- ----------------------------------- -------------- ---------------------------- -------------- ------------------------------------
  Houben \[[@R33]\]     2003   Prospective observational                     29                25                        0.62            0.17 (*P* = 0.032)                  --             --                           --             --
  Lok \[[@R34]\]        2003   Prospective sequential observational          451               Same as control           --                                                  0.12           0.1 (*P* = ns)               0.52           0.35 (*P* = 0.034)
  McCarley \[[@R35]\]   2001   Prospective sequential observational          132               Same as control           --              --                                  0.14/0.15^a^   0.07 (*P* = ns/  *P* = ns)   0.71/0.67^a^   0.16 (*P* \< 0.001/  *P* \< 0.001)
  Ram \[[@R36]\]        2003   Randomized controlled                         34/35^a^          32                        --              --                                  --             --                           0.68/0.5^a^    0.91 (*P* = unknown)
  Sands \[[@R37]\]      1999   Randomized controlled                         40                63                        1.25/0.303^a^   0.059 (*P* \< 0.01/  *P* \< 0.05)   --             --                           --             --
  Schwab \[[@R38]\]     2001   Prospective observational, historic control   --                42                        0.25            0.16 (*P* \< 0.05)                  0.16           0.07 (*P* \< 0.05)           0.3            0.22 (*P* = ns)
  Shahin \[[@R39]\]     2005   Prospective observational, historic control   146               76                        --              --                                  0.26           0.21 (*P* = ns)              --             --
  Wijnen \[[@R40]\]     2006   Retrospective                                 119               117                       0.63            0.25 (*P* = 0.000)                  0.21           0.09 (*P* = 0.022)           1.14           0.45 (*P* = 0.000)

AVF = arteriovenous fistula, AVG = arteriovenous graft, Qa = vascular access flow. ^a^Three trials had two control groups: McCarley \[35\], no monitoring/dynamic venous pressure monitoring; Ram \[36\], clinical criteria/quarterly duplex ultrasound assessment; Sands \[37\], no monitoring/static venous pressure monitoring.

All studies used the same pre-emptive intervention(s) in the control group and the Qa surveillance group. The referral for intervention used in the control groups was either based on conservative, often not standardized, surveillance parameters (inspection, palpation, auscultation and Kt/V) \[[@R39]\] or other surveillance tools (venous (static) pressure recordings \[[@R35],[@R37],[@R38]\] and duplex ultrasound \[[@R34],[@R36]\]). The only exception was the study by Hoeben *et al*. \[[@R33]\]. They compared two groups with exactly the same surveillance protocol, in which only one group had pre-emptive intervention. In the control group, no timely intervention took place after positive Qa criteria.

Methodological quality of the studies {#S3-4}
-------------------------------------

The allocation concealment assessment using the Cochrane scoring system revealed two randomized controlled trials with a grade B score (unclear concealment) \[[@R36]\]. The remaining 6 trials \[[@R33],[@R38]\] were all non-randomized controlled trials (Table [2](#T2){ref-type="table"}).

Discussion {#S4}
==========

Besides the fact that the methodological quality of most of the included studies is not suitable for an adequate statistical analysis of the results presented in Table [2](#T2){ref-type="table"}, there are some other important issues retrieved from the studies that illustrate that an adequate comparison is not possible.

Although seven out of eight studies reported a thrombosis decline using online Qa monitoring, not all of the results were significant. The only trial that reports a higher thrombosis frequency in AVG when compared to the control group \[[@R36]\] has an important caveat: referral for angiography was only indicated when Qa was \<600 ml/min, neglecting the 20--25% Qa decrease. In the current guidelines, both the absolute flow and the percentual reduction compared to previous flow measurements are used as indicators for intervention \[[@R2]\]. Waiting for Qa to drop beneath an absolute flow of 600 ml/min is questionable because a drop of \>25% seems to be more sensitive towards stenosis compared to an absolute flow of \<600 ml/min \[[@R23],[@R29]\]. Only a few papers reported the time of measurement during dialysis and none described the haemodynamic circumstances during which Qa was measured. Comparing a Qa result measured during normal blood pressure to a Qa result measured during low blood pressure may result in a false positive Qa decline (Equation ([1](#M1){ref-type="disp-formula"})) \[[@R41]\]. The factors influencing access flow in arteriovenous graft are given in the following equation: where MAP is the mean arterial pressure, *R*~ART~ is the resistance feeding artery, *R*~AA~ is the resistance arterial anastomosis, *R*~GRAFT~ is the resistance graft, *R*~VA~ is the resistance venous anastomosis and *R*~VEIN~ is the resistance outflow vein.

In the majority of haemodialysis patients, haemodynamics are far from stable. Rehman *et al*. \[[@R42]\] concluded that in the majority of patients, Qa measurements can be performed up to 2.5 h from the start of dialysis treatment, but in patients with a decreased mean arterial pressure (MAP) of \>15%, these authors advise to perform Qa measurement in the first 90 min after starting haemodialysis or postpone it to another treatment session when MAP is more stable.

All trials used the reference technique (saline dilution) to measure Qa; however, it is important to realize that using a different and less accurate technique to measure Qa may cause severe Qa decline to be missed or unnecessary interventions. The trials that studied reproducibility of different online access flow measurement techniques identified significant differences \[[@R43]\]. Considering these differences in accuracy, it is reasonable to imagine that the use of a less accurate Qa measurement device may result in unnecessary interventions and severe Qa decline to be missed, although no study has yet addressed this issue.

An important advantage of Qa monitoring, i.e. the ability to screen the whole vascular access circuit, is often overlooked (Figure [1](#F1){ref-type="fig"}). Only two out of eight retrieved trials \[[@R33],[@R39]\] reported the segment of the access that was screened during angiography (arterial anastomosis and venous segment). The occurrence of arterial inflow stenosis is under-recognized and may be the primary problem of 20--30% of dysfunctional grafts \[[@R9]\]. However, radiological evaluation often primarily focuses on outflow pathology. In a recent study \[[@R45]\], the value of angiographic evaluation of the whole vascular access circuit was shown. Patients were referred for angiography when Qa was \<600 ml/min or Qa decreased by \>25%. Overall inflow stenosis was diagnosed in 77/223 (35%) of cases (40% in arteriovenous fistula (AVF), 29% in AVG). Based on these results, the authors conclude that angiographic evaluation of access inflow should also be performed if patients are referred based on the results of Qa monitoring.

![Schematic rendering of resistances in the vascular access graft circuit. RA = right atrium, LV = left ventricle, *R*~ART~ = resistance feeding artery, *R*~AA~ = resistance arterial anastomosis, *R*~GRAFT~ = resistance graft, *R*~VA~ = resistance venous anastomosis, *R*~VEIN~ = resistance outflow vein. Stenosis detection span of control of vascular access flow monitoring. Stenosis detection span of control of static intra access pressure ratio monitoring.](sfn136fig1){#F1}

Only one study \[[@R33]\] reported the maximum time (8 weeks) it took to intervene after the reached cut-off value. They reported that five patients developed thrombosis before the scheduled pre-emptive intervention (total number of patients included was 86). In our own unit we schedule patients in the course of a week after positive Qa criteria. Even then, when Qa decline is severe, patients are scheduled in the course of 2 days for pre-emptive intervention. Although no study has yet addressed this issue, we advocate that intervention should take place in the course of 1 or 2 weeks after the identification of positive Qa criteria to prevent unnecessary thrombosis.

Final reflections {#S4-1}
-----------------

There is of course some evidence and rationale supporting the recommendations of the K/DOQI guidelines and the European Best Practice Guidelines that online Qa surveillance is the preferred surveillance tool for stenosis detection when compared to the described alternatives. Although observation of clinical signs (e.g. prolonged bleeding) should not be abandoned, online Qa measurement has been shown to be more accurate in identifying significant stenosis even before clinical symptoms appear \[[@R23],[@R29]\]. Static venous pressure only registers outflow stenosis (Figure [1](#F1){ref-type="fig"}) and has less sensitivity compared to access flow \[[@R46]\]. Recirculation is recognized as a very late finding of stenosis, and therefore is surely not suitable for grafts because these will not remain patent at flows lower than the extracorporeal blood pump speed \[[@R47]\].

However, our review identified that, to date, there is no convincing evidence that online Qa surveillance, when combined with pre-emptive intervention, has a significant effect on the rate of thrombosis.

To obtain an unambiguous answer through future research, multiple factors need to be in place. These include choice and application of available guidelines and, importantly, successful PTA and/or surgical intervention. Post-PTA Qa measurement during angiography evaluates the effect of the intervention and might improve intervention sensitivity \[[@R48]\]. Also, it is known that PTA causes further injury to the vessel wall and may accelerate the disease process of intimal hyperplasia \[[@R49]\]. Alternative therapies in the treatment of intimal hyperplasia might improve vascular access patency. Regarding Qa measurement frequency, it has recently been suggested that frequency should be increased when compared to the suggested monthly measurement \[[@R50]\].

Another major drawback of the identified studies is that they are statistically inadequate to account for multiple related factors that include blood pressure measurement at the time of Qa measurement, angiographic evaluation of the vascular access circuit, time till intervention after positive Qa criteria, patient vascular access prehistory, age of the graft and adequate post-PTA flow increase. Also, one must take into consideration that most of these factors differ between AVG and AVF. Each group in a randomized controlled trial should have \>200 patients, so only a large multi-centre study may provide statistically adequate data.

In conclusion, our review identified that there is no convincing evidence that online Qa surveillance, when combined with pre-emptive intervention, has a significant effect on the rate of thrombosis. Future large-scale studies with adequate study design, adequate surveillance and intervention protocols and possibly better pre-emptive intervention alternative(s) are necessary.
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